Diabetic Care Devices Global Market Report 2020-30: COVID-19 Implications and Growth from the publisher covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for diabetic care devices as people with diabetes are at increased risk of serious illness from COVID-19.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the diabetic care devices market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Diabetic Care Devices Market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider diabetic care devices market, and compares it with other markets.
Scope
Markets Covered:
1) By Type: Blood Glucose Test Strips; Insulin Pens, Syringes, Pumps And Injectors; Lancing Devices And Equipment; Continuous Glucose Monitoring Devices And Equipment; Blood Glucose Meters
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Subsegments Covered: Glucose Dehydrogenase; Glucose Oxidase; Pens; Injectors And Pumps; Syringes
Companies Mentioned: Roche; Medtronic; J&J; Abbott; Becton, Dickinson and Company
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, diabetes care devices indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the diabetic care devices market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Diabetic Care Devices Market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider diabetic care devices market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The diabetic care devices market section of the report gives context. It compares the diabetic care devices market with other segments of the diabetic care devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, diabetic care devices indicators comparison.
Scope
Markets Covered:
1) By Type: Blood Glucose Test Strips; Insulin Pens, Syringes, Pumps And Injectors; Lancing Devices And Equipment; Continuous Glucose Monitoring Devices And Equipment; Blood Glucose Meters
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Subsegments Covered: Glucose Dehydrogenase; Glucose Oxidase; Pens; Injectors And Pumps; Syringes
Companies Mentioned: Roche; Medtronic; J&J; Abbott; Becton, Dickinson and Company
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, diabetes care devices indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
1. Executive Summary2. Report Structure7. Diabetes Care Devices Market Trends And Strategies21. Key Mergers And Acquisitions In The Diabetes Care Devices Market25. Copyright And Disclaimer
3. Diabetes Care Devices Market Characteristics
4. Diabetes Care Devices Market Product Analysis
5. Diabetes Care Devices Market Supply Chain
6. Diabetes Care Devices Market Customer Information
8. Diabetes Care Devices Market Size And Growth
9. Diabetes Care Devices Market Regional Analysis
10. Diabetes Care Devices Market Segmentation
11. Diabetes Care Devices Market Segments
12. Diabetes Care Devices Market Metrics
13. Asia-Pacific Diabetes Care Devices Market
14. Western Europe Diabetes Care Devices Market
15. Eastern Europe Diabetes Care Devices Market
16. North America Diabetes Care Devices Market
17. South America Diabetes Care Devices Market
18. Middle East Diabetes Care Devices Market
19. Africa Diabetes Care Devices Market
20. Diabetes Care Devices Market Competitive Landscape
22. Market Background: Medical Equipment Market
23. Recommendations
24. Appendix
Note: Product cover images may vary from those shown
North America was the largest region in the global diabetes care devices market, accounting for 48% of the market in 2019. Western Europe was the second largest region accounting for 19% of the global diabetes care devices market. Africa was the smallest region in the global diabetes care devices market.
The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM), and transmits this information to an insulin pump that calculates and releases the required amount of insulin into the body. It consists of three essential components – a glucose sensor system, a control algorithm, and an insulin infusion device. This system is more effective than conventional insulin delivery devices as it automates insulin dosing based on blood sugar levels. Key companies in this industry are focusing on developing such systems. Medtronic recently gained US FDA approval for its artificial pancreas system, MiniMed 670G.
The diabetes care devices (or) equipment consists of sales of diabetes care devices and related services by entities (organizations, sole traders and partnerships) that produce diabetes care devices used to monitor blood glucose levels in diabetic patients. This industry includes establishments that produce blood glucose test strips used to check blood glucose levels, Insulin Pens, Syringes, pumps and Injectors used to inject insulin, continuous glucose monitoring devices, blood glucose meters and others.
The global diabetes care devices market is expected to grow from $35.2 billion in 2019 to $37.3 billion in 2020 at a compound annual growth rate (CAGR) of 5.9%. The growth is mainly due to the COVID-19 outbreak as people with diabetes are at increased risk of serious illness from COVID-19. The diabetic care devices are increasingly being used by care providers and patients (self-monitor) to frequently check the blood glucose levels. FDA issued guidance to expand the availability and capability of non-invasive remote monitoring devices including continuous glucose monitors (CGM) during the COVID-19 pandemic. However, the growth is not as significant as expected due to the demand and supply gaps. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $47.3 billion in 2023.
The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM), and transmits this information to an insulin pump that calculates and releases the required amount of insulin into the body. It consists of three essential components – a glucose sensor system, a control algorithm, and an insulin infusion device. This system is more effective than conventional insulin delivery devices as it automates insulin dosing based on blood sugar levels. Key companies in this industry are focusing on developing such systems. Medtronic recently gained US FDA approval for its artificial pancreas system, MiniMed 670G.
The diabetes care devices (or) equipment consists of sales of diabetes care devices and related services by entities (organizations, sole traders and partnerships) that produce diabetes care devices used to monitor blood glucose levels in diabetic patients. This industry includes establishments that produce blood glucose test strips used to check blood glucose levels, Insulin Pens, Syringes, pumps and Injectors used to inject insulin, continuous glucose monitoring devices, blood glucose meters and others.
The global diabetes care devices market is expected to grow from $35.2 billion in 2019 to $37.3 billion in 2020 at a compound annual growth rate (CAGR) of 5.9%. The growth is mainly due to the COVID-19 outbreak as people with diabetes are at increased risk of serious illness from COVID-19. The diabetic care devices are increasingly being used by care providers and patients (self-monitor) to frequently check the blood glucose levels. FDA issued guidance to expand the availability and capability of non-invasive remote monitoring devices including continuous glucose monitors (CGM) during the COVID-19 pandemic. However, the growth is not as significant as expected due to the demand and supply gaps. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $47.3 billion in 2023.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Roche
- Medtronic
- J&J
- Abbott
- Becton, Dickinson and Company
Note: Product cover images may vary from those shown
LOADING...
![Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] - Global Forecast to 2028 - Product Image](http://www.researchandmarkets.com/product_images/12194/12194704_60px_jpg/diabetes_care_devices_market.jpg)
